What are BioMarin Pharmaceuticals's profit margins?

BioMarin Pharmaceuticals (BMRN) runs a 76.5% gross margin and a 19.9% operating margin, with a 16.8% net margin.

Where do BioMarin Pharmaceuticals's ratios come from?

Every ratio is computed from BioMarin Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

BioMarin Pharmaceuticals BMRN Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	77.7%-1.9pp	79.7%+1.7pp	78%+2.0pp	76%+1.5pp
EBITDA margin	16.7%-3.7pp	20.3%+8.4pp	12%-1.2pp	13.2%+11.8pp
Free cash flow margin	22.5%+5.4pp	17.1%—	——	——
Returns
Return on invested capital	6.6%-1.4pp	8%+4.2pp	3.8%-0.8pp	4.6%+6.8pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.3×0.0×
Inventory turnover	0.6×+0.1×	0.5×0.0×	0.5×-0.1×	0.6×0.0×
Liquidity
Current ratio	5.2×-0.1×	5.3×+2.8×	2.5×-2.2×	4.7×+0.5×
Quick ratio	3.5×+0.2×	3.3×+1.7×	1.6×-1.6×	3.2×+0.4×
Cash ratio	1.7×+0.2×	1.6×+0.9×	0.6×-0.6×	1.2×+0.2×
Leverage
Debt-to-equity	0.1×+0.1×	0×-0.1×	0.1×+0.1×	0×0.0×
Debt-to-assets	0.1×+0.1×	0×-0.1×	0.1×+0.1×	0×0.0×
Net debt / EBITDA	-1.2×+0.3×	-1.6×-0.8×	-0.7×+1.8×	-2.5×+18.6×
Interest coverage	41.9×+3.7×	38.2×+27.5×	10.7×-0.2×	10.9×+16.3×
Per Share
Book value per share	$30.84+7.2%	$28.76+11.3%	$25.84+6.1%	$24.36+4.4%
Valuation
Market capitalization	$11.42B-8.9%	$12.53B-31.0%	$18.16B-5.6%	$19.23B+18.6%
Enterprise value	$10.75B-7.5%	$11.62B-35.2%	$17.95B-3.2%	$18.55B+18.3%
Price / sales	3.5×-0.8×	4.4×-3.1×	7.5×-1.7×	9.2×+0.4×
Price / book	1.9×-0.3×	2.2×-1.5×	3.7×-0.5×	4.2×+0.4×
EV / EBITDA	20×0.0×	20×-41.8×	61.9×-5.3×	67.2×-543×
EV / sales	3.3×-0.7×	4.1×-3.3×	7.4×-1.4×	8.8×+0.4×
Free cash flow yield	6.3%+2.5pp	3.9%—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about BioMarin Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are BioMarin Pharmaceuticals's profit margins?: BioMarin Pharmaceuticals (BMRN) runs a 76.5% gross margin and a 19.9% operating margin, with a 16.8% net margin.
Where do BioMarin Pharmaceuticals's ratios come from?: Every ratio is computed from BioMarin Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.